Investigating how proteins behave differently in various cell types in human diseases
Integrative Approaches to Study Cell-Type-Specific Protein Dysregulation in Human Diseases
This study is looking at how certain proteins behave differently in various cells related to diseases like Alzheimer's and cancer, with the goal of finding new ways to treat these conditions and help patients get more personalized care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10938179 on NIH RePORTER |
What this research studies
This research focuses on understanding the specific protein dysregulation in different cell types associated with complex diseases like Alzheimer's and cancer. By utilizing advanced techniques such as single-cell RNA sequencing and mass spectrometry, the study aims to profile protein-level changes that occur in these diseases. This approach will help identify potential biomarkers and therapeutic targets, ultimately leading to better treatment strategies. Patients may benefit from insights gained about their specific disease mechanisms and tailored therapies based on their unique cellular profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or other complex conditions characterized by protein dysregulation.
Not a fit: Patients with non-complex diseases or those not exhibiting significant protein dysregulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with complex diseases.
How similar studies have performed: Previous research has shown promise in using proteogenomics to understand disease mechanisms, indicating that this approach could yield valuable insights.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Huang, Chen — University of Alabama at Birmingham
- Study coordinator: Huang, Chen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.